| Schedule of Fair Value of Derivative Instruments in Statement of Financial Position |
As of March 31, 2026 and December 31, 2025, our foreign exchange forward contracts consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2026 | | December 31, 2025 | | Notional Value | | Fair Value (Level 2) | | Balance Sheet Location | | Notional Value | | Fair Value (Level 2) | | Balance Sheet Location | | (In thousands) | | Forward contracts not designated as hedging instruments | | Euro dollar | $ | 25,174 | | | $ | 165 | | | Other current assets | | $ | 17,880 | | | $ | (6) | | | Accrued expenses | | Japanese yen | 223,467 | | | 1,140 | | | Other current assets | | 253,313 | | | (848) | | | Accrued expenses | | Korean won | 70,103 | | | 646 | | | Other current assets | | 82,752 | | | (601) | | | Accrued expenses | | Philippine peso | 10,685 | | | (4) | | | Accrued expenses | | 13,114 | | | (76) | | | Accrued expenses | | Singapore dollar | 27,696 | | | (30) | | | Accrued expenses | | 11,566 | | | (27) | | | Accrued expenses | | Taiwan dollar | 40,666 | | | (165) | | | Accrued expenses | | 36,598 | | | (59) | | | Accrued expenses | | Total forward contracts not designated as hedging instruments | $ | 397,791 | | | $ | 1,752 | | | | | $ | 415,223 | | | $ | (1,617) | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2026 | | December 31, 2025 | | Notional Value | | Fair Value (Level 2) | | Balance Sheet Location | | Notional Value | | Fair Value (Level 2) | | Balance Sheet Location | | (In thousands) | | Forward contracts designated as net investment hedging instruments | | Japanese yen | $ | 121,243 | | | $ | (646) | | | Accrued expenses | | $ | 123,846 | | | $ | 425 | | | Other current assets | | Total forward contracts designated as net investment hedging instruments | $ | 121,243 | | | $ | (646) | | | | | $ | 123,846 | | | $ | 425 | | | |
|
| Schedule of Derivative Instruments, Gain (Loss) |
The following table presents the gain or loss recognized on our derivatives designated as net investment hedging instruments for the three months ended March 31, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended March 31, | | Location on Consolidated Financial Statements | | 2026 | | 2025 | | | | (In thousands) | | Difference between forward rate and spot rate of the forward contracts | Other (income) expense, net | | $ | (980) | | | $ | (1,318) | | | Changes in fair value of forward contracts | Other comprehensive income (loss) | | $ | 1,173 | | | $ | (4,709) | |
|